.Attributes Medication, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective asks for addition of people along with MASLD and also dimension of liver results in cardio-- renal-- metabolic tests, when records suggest mechanistically conceivable advantages as well as clinical safety-- and also outlines factors to consider for trial design and regulative approval.